Form 8-K - Current report:
SEC Accession No. 0001193125-20-164664
Filing Date
2020-06-09
Accepted
2020-06-09 16:16:04
Documents
14
Period of Report
2020-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933868d8k.htm   iXBRL 8-K 62613
2 EX-3.1 d933868dex31.htm EX-3.1 214049
3 EX-10.1 d933868dex101.htm EX-10.1 23562
  Complete submission text file 0001193125-20-164664.txt   478222

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA teva-20200609.xsd EX-101.SCH 3072
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20200609_lab.xml EX-101.LAB 19590
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20200609_pre.xml EX-101.PRE 12292
15 EXTRACTED XBRL INSTANCE DOCUMENT d933868d8k_htm.xml XML 3972
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 20951998
SIC: 2834 Pharmaceutical Preparations